Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice-Reference-Cited by-同舟云学术

Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice

Published:2007-01-03 Issue:1 Volume:106 Page:29-38
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Wagner Stefan,Jasinska Joanna,Breiteneder Heimo,Kundi Michael,Pehamberger Hubert,Scheiner Otto,Zielinski Christoph C.,Wiedermann Ursula

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-006-9469-4.pdf

Reference20 articles.

1. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI (1994) The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9:2109–2123

2. Masood S, Bui MM (2002) Prognostic and predictive value of HER2/neu oncogene in breast cancer. Microsc Res Tech 59:102–108

3. Disis ML, Gralow JR, Bernhard H, Hand SL, Rubin WD, Cheever MA (1996) Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein. J Immunol 156:3151–3158

4. Dakappagari NK, Douglas DB, Triozzi PL, Stevens VC, Kaumaya PT (2000) Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine. Cancer Res 60:3782–3789

5. Dakappagari NK, Pyles J, Parihar R, Carson WE, Young DC, Kaumaya PT (2003) A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses. J Immunol 170:4242–4253

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Biomimetic, Silaffin R5-Based Antigen Delivery Platform;Pharmaceutics;2022-12-29

2. Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers;Frontiers in Oncology;2022-12-12

3. Peptide antitumor vaccines targeting HER2/neu;Russian Journal of Biotherapy;2022-12-10

4. Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer;Cancers;2022-11-18

5. Peptides for Vaccine Development;ACS Applied Bio Materials;2022-02-23